Osteonecrosis of the jaw and bevacizumab therapy

Breast Cancer Research and Treatment

Volumn 122, Issue 1, 2010, Pages 189-191

  Van Poznak, Catherine ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; BISPHOSPHONIC ACID DERIVATIVE; DENOSUMAB; PLACEBO; SUNITINIB; ZOLEDRONIC ACID; ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; MONOCLONAL ANTIBODY;

ANTIANGIOGENIC ACTIVITY; BONE METASTASIS; BREAST CANCER; CANCER STAGING; CLINICAL TRIAL; DRUG EFFICACY; DRUG EXPOSURE; DRUG MECHANISM; DRUG SURVEILLANCE PROGRAM; HUMAN; JAW OSTEONECROSIS; NONHUMAN; NOTE; OSTEOPOROSIS; OUTCOME ASSESSMENT; PAGET BONE DISEASE; PATHOGENESIS; PRIORITY JOURNAL; RISK FACTOR; TOOTH EXTRACTION; BREAST NEOPLASMS; CHEMICALLY INDUCED; COMPLICATION; DRUG POTENTIATION; FEMALE; INCIDENCE; JAW DISEASES; METASTASIS; MULTICENTER STUDY (TOPIC); OSTEONECROSIS; PATHOLOGY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; DIPHOSPHONATES; DRUG SYNERGISM; FEMALE; HUMANS; INCIDENCE; JAW DISEASES; MULTICENTER STUDIES AS TOPIC; NEOPLASM METASTASIS; OSTEONECROSIS; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; ANTIBODIES, MONOCLONAL, HUMANIZED;

EID: 77953544440     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-010-0933-9     Document Type: Note

References (19)

1. IR Reid 2009 Osteonecrosis of the jaw-who gets it, and why? Bone 44 1 4 10 10.1016/j.bone.2008.09.012 1:CAS:528:DC%2BD1cXhsFahtLnK 18948230
2. JB Aragon-Ching YM Ning CC Chen L Latham JP Guadagnini JL Gulley PM Arlen JJ Wright H Parnes WD Figg WL Dahut 2009 Higher incidence of osteonecrosis of the jaw (ONJ) in patients with metastatic castration resistant prostate cancer treated with anti-angiogenic agents Cancer Investig 27 221 226 10.1080/07357900802208608 1:CAS:528:DC%2BD1MXktFKitbg%3D
3. Khosla S, Burr D, Cauley J, Dempster DW, Ebeling P, Felsenberg D, Gagel RF, Gilsanz V, Guise T, Koka S, McCauley LK, McGowan J, McKee MD, Mohla S, Pendrys DG, Raisz LG, Ruggiero SL, Shafer DM, Shum L, Silverman SL, Van Poznak CH, Watts N, Woo S-B, Shane E (2007) Bisphosphonate-associated osteonecrosis of the jaw: report of a Task Force of the American Society for Bone and Mineral Research. J Bone Miner Res 1479-1491
4. D Mauri A Valachis IP Polyzos NP Polyzos K Kamposioras LL Pesce 2009 Osteonecrosis of the jaw and use of bisphosphonates in adjuvant breast cancer treatment: a metaanalysis Breast Cancer Res Treat 116 433 439 10.1007/s10549-009-0432-z 1:CAS:528:DC%2BD1MXhtFGmtrzI 19521766
5. Kolata G (2006) Drug for bones is newly linked to jaw disease. The New York Times June 2
6. Almazrooa SA, Woo SB (2009) Bisphosphonate and nonbisphosphonate- associated osteonecrosis of the jaw: a review. J Am Dent Assoc 140(7):864-867
7. R Gliklich J Wilson 2009 Epidemiology of bisphosphonate-related osteonecrosis of the jaws: the utility of a national registry J Oral Maxillofac Surg 67 5, Suppl 71 74 10.1016/j.joms.2009.01.005 19371817
8. MC Winter I Holen RE Coleman 2008 Exploring the anti-tumour activity of bisphosphonates in early breast cancer Cancer Treat Rev 34 5 453 475 10.1016/j.ctrv.2008.02.004 1:CAS:528:DC%2BD1cXosVymur0%3D 18423992 (Aug)
9. MR Allen DB Burr 2009 The pathogenesis of bisphosphonate-related osteonecrosis of the jaw: so many hypotheses, so few data J Oral Maxillofac Surg 67 5, Suppl 61 70 10.1016/j.joms.2009.01.007 19371816
10. Guarneri V, Miles D, Robert N, Diéras V, Glaspy J, Smith I, Thomssen C, Biganzoli L, Taran T, Conte P (2010) Bevacizumab and osteonecrosis of the jaw: incidence and association with bisphosphonate therapy in three large prospective trials in advanced breast cancer. Breast Cancer Res Treat. doi: 10.1007/s10549-010-0866-3
11. BJ Edwards M Gounder JM McKoy I Boyd M Farrugia C Migliorati R Marx S Ruggiero M Dimopoulos DW Raisch S Singhal K Carson E Obadina S Trifilio D West J Mehta CL Bennett 2008 Pharmacovigilance and reporting oversight in US FDA fast-track process: bisphosphonates and osteonecrosis of the jaw Lancet Oncol 9 12 1166 1172 10.1016/S1470-2045(08)70305-X 19038763
12. A Kyrgidis 2010 Bisphosphonate-related osteonecrosis of the jaw in randomized clinical trials Breast Cancer Res Treat 119 253 254 10.1007/s10549-009-0466-2 19585235
13. American Association of Oral and Maxillofacial Surgeons 2007 Position paper on bisphosphonate-related osteonecrosis of the jaw J Oral Maxillofac Surg 65 369 376 10.1016/j.joms.2006.11.003 (Pubitemid 46329248)
14. K Vahtsevanos A Kyrgidis E Verrou E Katodritou S Triaridis C Andreadis I Boukovinas G Koloutsos Z Teleioudis K Kitikidou P Paraskevopoulos K Zervas K Antoniades 2009 Bisphosphonate related osteonecrosis of the jaws: a longitudinal cohort study of risk factors in cancer patients J Clin Oncol 27 32 5356 5362 10.1200/JCO.2009.21.9584 1:CAS:528:DC%2BD1MXhsFKkt7rF 19805682
15. HL McArthur C Estilo J Huryn T Williams M Fornier TA Traina J Howard CA Hudis MN Dickler 2008 Osteonecrosis of the jaw (ONJ) among intravenous (IV) bisphosphonate- and/or bevacizumab-treated patients (pts) at Memorial Sloan-Kettering Cancer Center (MSKCC) J Clin Oncol 26 9588
16. A Stopeck JJ Body Y Fujiwara A Lipton GG Steger M Viniegra M Fan A Braun R Dansey S Jun 2009 Denosumab versus zoledronic acid for the treatment of breast cancer patients with bone metastases: results of a randomized phase 3 study Eur J Cancer Suppl 7 3 2 10.1016/S1359-6349(09)72028-2 (abstract 2LBA)
17. D Henry R von Moos S Vadhan-Raj V Hungria A Spencer V Hirsh J Wang S Jun H Yeh R Dansey 2009 A double-blind, randomized study of denosumab versus zoledronic acid for the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer) or multiple myeloma Eur J Cancer Suppl 7 3 11 10.1016/S1359-6349(09)72055-5 (abstract 20LBA)
18. National Institute of Health Research Portfolio Online Reporting Tools http://projectreporter.nih.gov/reporter.cfm 1R03DE019684-01A1. Accessed 15 Apr 2010
19. C Van Poznak 2006 The phenomenon of osteonecrosis of the jaw in patients with metastatic breast cancer Cancer Investig 24 110 112 10.1080/ 07357900500449652 (Pubitemid 43247281)